HGG

4 drugs in development·3 companies·1 clinical trial

Drug Pipeline by Phase

Phase 2(1)

Drug	Company
CLD-101 (NeuroNova™)	Calidi Biotherapeutics Inc. (CLDI)

Phase 1(2)

Drug	Company
CAN-3110	Candel Therapeutics, Inc. (CADL)
linoserpaturev	Candel Therapeutics, Inc. (CADL)

Preclinical(1)

Drug	Company
ateganosine	MAIA Biotechnology, Inc. (MAIA)

BioSniper tracks 4 drugs in development for HGG across 3 companies.

There are 1 clinical trial targeting HGG tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.